Allergy and Immunology · San Diego, CA
NPI
1750352761
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3811 Valley Centre Dr
San Diego, CA, 92130
Phone (858) 764-9010
Groups this clinician bills Medicare through
Medicare paid, 2024
$619K
32,554 services
Medicare patients, 2024
488
Average age 73
Drug cost, 2024
$1.5M
1,568 prescriptions
Company payments, 2025
$151K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew White was code J2357 (injection, omalizumab, 5 mg), 9,090 times for 54 patients. In total Andrew White billed 32,554 services in 56 codes, and Medicare paid $619K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 9,090 | 54 | $21.54 | $196K |
| J2182 Injection, mepolizumab, 1 mg | Office | 8,700 | 21 | $20.77 | $181K |
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 7,980 | 14 | $11.97 | $95K |
| 95004 Test - Miscellaneous | Office | 1,737 | 51 | $3.04 | $5,289 |
| 95044 Test - Miscellaneous | Office | 1,105 | 16 | $4.37 | $4,829 |
| 95165 Treatment - Miscellaneous | Office | 456 | 20 | $11.85 | $5,404 |
| 96372 Injection Administration | Office | 445 | 104 | $11.96 | $5,321 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 238 | 181 | $13.13 | $3,126 |
| 95117 Treatment - Miscellaneous | Office | 230 | 55 | $10.77 | $2,478 |
| 99213 Office E&M - Established | Office | 218 | 175 | $71.00 | $15K |
| 99214 Office E&M - Established | Office | 112 | 86 | $100.20 | $11K |
| 95115 Treatment - Miscellaneous | Office | 107 | 26 | $8.31 | $889 |
| 99204 Office E&M - New | Office | 94 | 94 | $131.88 | $12K |
| 94010 Pulmonary Function Testing | Office | 56 | 50 | $22.72 | $1,272 |
| 95012 Pulmonary | Office | 54 | 45 | $17.17 | $927 |
By year: 2022 $392K for 19,229 services; 2023 $505K for 24,807 services; 2024 $619K for 32,554 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew White prescribed most often to Medicare patients was Montelukast Sodium, with 157 prescriptions and refills. In total Andrew White wrote 1,568 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 157 | 410 | 44 | $2,493 |
| Dupixent Pen Dupilumab | 108 | 112 | 15 | $415K |
| Azelastine Hcl Generic | 101 | 167 | 36 | $4,301 |
| Xolair Omalizumab | 92 | 97 | Under 11 | $345K |
| Prednisone Generic | 77 | 79 | 41 | $324 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 69 | 91 | 34 | $2,253 |
| Ipratropium Bromide Generic | 64 | 102 | 25 | $2,341 |
| Cromolyn Sodium Generic | 56 | 75 | 11 | $29K |
| Azithromycin Generic | 52 | 52 | 38 | $200 |
| Nucala Mepolizumab | 46 | 46 | Under 11 | $175K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 44 | 68 | 14 | $12K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 39 | 55 | Under 11 | $34K |
| Dupixent Syringe Dupilumab | 38 | 38 | Under 11 | $144K |
| Spiriva Respimat Tiotropium Bromide | 34 | 54 | Under 11 | $27K |
| Breyna Budesonide/Formoterol Fumarate | 30 | 44 | Under 11 | $5,258 |
Brand drugs: - claims; generic drugs: 910 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew White $151K ($147K in general payments such as food, travel and fees and $4,414 for research) from 31 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $43K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 40 | $43K |
| GlaxoSmithKline, LLC. GSK | 50 | $37K |
| Genzyme Corporation SNY | 21 | $17K |
| Blueprint Medicines Corporation SNY | 16 | $14K |
| AstraZeneca Pharmaceuticals LP AZN | 30 | $13K |
| Sanofi US Services Inc. SNY | 8 | $13K |
| Regeneron Pharmaceuticals, Inc. REGN | 7 | $4,713 |
| Optinose US, Inc. | 7 | $2,651 |
| Genentech USA, Inc. ROG.SW | 2 | $2,180 |
| Eli Lilly and Company LLY | 1 | $1,400 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.